Zobrazeno 1 - 10
of 261
pro vyhledávání: '"Tzu-Hsien Tsai"'
Autor:
Ming-Lung Tsai, Yuan Lin, Ming-Shyan Lin, Tzu-Hsien Tsai, Ning-I Yang, Chao-Yung Wang, I-Chang Hsieh, Ming-Jui Hung, Tien-Hsing Chen
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 15, Iss 1, Pp 1-12 (2023)
Abstract Background and aims Clinical comparisons of angiotensin receptor–neprilysin inhibitors (ARNI) and sodium–glucose cotransporter 2 inhibitors (SGLT2i) treatment in patients with HFrEF and T2DM are limited. This study evaluated the clinical
Externí odkaz:
https://doaj.org/article/50681a385e1f4a9a89c36429eaa0c8c7
Autor:
Yuan Lin, Te-Hsiung Wang, Ming-Lung Tsai, Victor Chien-Chia Wu, Chin-Ju Tseng, Ming-Shyan Lin, Yan-Rong Li, Chih-Hsiang Chang, Tien-Shin Chou, Tzu-Hsien Tsai, Ning-I Yang, Ming-Jui Hung, Tien-Hsing Chen
Publikováno v:
Cardiovascular Diabetology, Vol 22, Iss 1, Pp 1-11 (2023)
Abstract Background To determine whether glucagon-like peptide 1 receptor agonists (GLP-1RAs) have cardiovascular and renal protective effects in patients with advanced diabetic kidney disease (DKD) with an estimated glomerular filtration rate (eGFR)
Externí odkaz:
https://doaj.org/article/28ce83582cd14ad9a80819fa3b02b39a
Autor:
Po-Sheng Chen, Wen-Han Feng, Tzu-Hsien Tsai, Yi-Kai Hong, An-Sheng Lee, Kuan-Cheng Chang, Hsing-Chun Chung, Yen-Wen Liu, Chih-Cheng Hsieh, Yi-Hsian Fang, Pei-Jung Yang, Chawn-Yau Luo, Ping-Yen Liu, Tsung-Lin Cheng, Yi-Heng Li
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-13 (2022)
Abstract Tumor endothelial marker 1 (TEM1) is a transmembrane glycoprotein that appears on mesenchymal lineage-derived cells during embryogenesis, but its expression greatly reduces after birth. Re-upregulation of TEM1 is found in tumor angiogenesis,
Externí odkaz:
https://doaj.org/article/7208fc269d5d460581b974c4390d6bef
Autor:
Chung‐Yuan Hsu, Yu‐Jih Su, Jia‐Feng Chen, Chi‐Chin Sun, Tien‐Tsai Cheng, Tzu‐Hsien Tsai, Shang‐Hong Lin, Cheng‐Chieh Chang, Tien‐Hsing Chen
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 8 (2021)
Background Cardiovascular disease is the most common cause of death in patients with rheumatoid arthritis. It is believed that using disease‐modifying antirheumatic drugs (DMARDs) to control inflammation can reduce the risk of cardiovascular diseas
Externí odkaz:
https://doaj.org/article/9e19a9f5cc834771b8934e9251d12535
Autor:
Wei‐Chieh Lee, Hsiu‐Yu Fang, Huang‐Chung Chen, Yung‐Lung Chen, Tzu‐Hsien Tsai, Kuo‐Li Pan, Yu‐Sheng Lin, Mien‐Cheng Chen
Publikováno v:
ESC Heart Failure, Vol 6, Iss 4, Pp 686-693 (2019)
Abstract Aims High demand right ventricular pacing may elicit left ventricular systolic dysfunction known as pacing‐induced cardiomyopathy, increasing the risks of heart failure (HF) hospitalization. Percentage of demand ventricular pacing is diffe
Externí odkaz:
https://doaj.org/article/9ca5ea441ea44f2bafefd947f7d83b63
Therapeutic Strategies for Targeting IL-33/ST2 Signalling for the Treatment of Inflammatory Diseases
Publikováno v:
Cellular Physiology and Biochemistry, Vol 49, Iss 1, Pp 349-358 (2018)
Interleukin (IL)-33, a member of the IL-1 family of cytokines, is involved in innate and adaptive immune responses via interaction with its receptor, ST2. Activation of ST2 signalling by IL-33 triggers pleiotropic immune functions in multiple ST2-exp
Externí odkaz:
https://doaj.org/article/b0cfe6fe8a514f8895fec42b2cc4ee9a
Autor:
Xinmeng Zhang, Zheng-Ian Lin, Jingyu Yang, Guan-Lin Liu, Zulu Hu, Haoqiang Huang, Xiang Li, Qiqi Liu, Mingze Ma, Zhourui Xu, Gaixia Xu, Ken-Tye Yong, Wei-Chung Tsai, Tzu-Hsien Tsai, Bao-Tsan Ko, Chih-Kuang Chen, Chengbin Yang
Publikováno v:
Nanomaterials, Vol 11, Iss 9, p 2312 (2021)
Pancreatic cancer is an aggressive malignancy associated with poor prognosis and a high tendency in developing infiltration and metastasis. K-ras mutation is a major genetic disorder in pancreatic cancer patient. RNAi-based therapies can be employed
Externí odkaz:
https://doaj.org/article/be8f70f9f7664e6ea98ac64b78472e0d
Autor:
Shyh-Ming Chen, Lin-Yi Wang, Po-Jui Wu, Mei-Yun Liaw, Yung-Lung Chen, An-Ni Chen, Tzu-Hsien Tsai, Chi-Ling Hang, Meng-Chih Lin
Publikováno v:
Diagnostics, Vol 10, Iss 7, p 469 (2020)
The relationship between left ventricular ejection fraction (LVEF) and cardiovascular (CV) outcome is documented in patients with low LVEF. Ventilatory inefficiency is an important prognostic predictor. We hypothesized that the presence of ventilator
Externí odkaz:
https://doaj.org/article/7c17dc5b07304f2e88ef3ee5f912aa9b
Autor:
Wen-Shuo Yeh, Shih-Cheng Yang, Chih-Ming Liang, Yu-Chi Li, Wei-Chen Tai, Chen-Hsiang Lee, Yao-Hsu Yang, Chien-Ning Hsu, Tzu-Hsien Tsai, Seng-Kee Chuah, Cheng-Kun Wu
Publikováno v:
Medicina, Vol 56, Iss 1, p 14 (2019)
Background and Objectives: Non-selective β-blockers (NSBB) could prevent decompensation and hepatocellular carcinoma (HCC) in cirrhotic patients with clinically significant portal hypertension (CSPH), but remained uncertain for compensated cirrhotic
Externí odkaz:
https://doaj.org/article/53d50dd0d6e84452af46fa7eb126a190
Autor:
Chih-Yuan Fang, Huang-Chung Chen, Yung-Lung Chen, Tzu-Hsien Tsai, Kuo-Li Pan, Yu-Sheng Lin, Mien-Cheng Chen, Wei-Chieh Lee
Publikováno v:
PeerJ, Vol 6, p e5312 (2018)
Background The use of an implantable cardioverter-defibrillator (ICD) has been established as an effective secondary prevention strategy for ventricular tachycardia (VT)/ventricular fibrillation (VF). However, few reports discuss the difference in cl
Externí odkaz:
https://doaj.org/article/eeab7d04181b45859fea907e655a7c58